Rufinamide in patients with Lennox-Gastaut syndrome
Peggy O Clark,1 Patricia A Gibson2 1Cincinnati Children’s Hospital Medical Center, The University of Cincinnati College of Medicine, Cincinnati, OH, 2Epilepsy Information Service, Wake Forest University School of Medicine, Winston-Salem, NC, USA Objectives: Lennox–Gastaut syndrom...
Main Authors: | Clark PO, Gibson PA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-11-01
|
Series: | Nursing: Research and Reviews |
Subjects: | |
Online Access: | https://www.dovepress.com/rufinamide-in-patients-with-lennox-gastaut-syndrome-peer-reviewed-article-NRR |
Similar Items
-
Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review
by: Balagura G, et al.
Published: (2020-02-01) -
Novel seizure outcomes in patients with Lennox‐Gastaut syndrome: Post hoc analysis of seizure‐free days in rufinamide Study 303
by: Stéphane Auvin, et al.
Published: (2019-06-01) -
Efficacy and Safety of Lamotrigine Adjunctive Therapy in Lennox-Gastaut Syndrome
by: Hui Jin Shin, et al.
Published: (2023-04-01) -
PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT
by: N. K. Mazina, et al.
Published: (2016-04-01) -
Diagnostics and age-related evolution of Lennox–Gastaut syndrome. Management in diverse patient age periods
by: E. D. Belousova, et al.
Published: (2022-10-01)